Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Czarnecka AM"'
Autor:
Czarnecka AM; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Department of Experimental Pharmacology, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland., Chmiel P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Medical Faculty, Warsaw Medical University, Warsaw, Poland., Błoński P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Medical Faculty, Warsaw Medical University, Warsaw, Poland., Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Publikováno v:
Expert review of anticancer therapy [Expert Rev Anticancer Ther] 2024 Jun; Vol. 24 (6), pp. 407-421. Date of Electronic Publication: 2024 Apr 30.
Autor:
Chmiel P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland., Krotewicz M; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland., Szumera-Ciećkiewicz A; Department of Pathology, Maria Sklodowska Curie National Research Institute of Oncology, 02-781 Warsaw, Poland., Bartnik E; Institute of Genetics and Biotechnology, Faculty of Biology, University of Warsaw, 02-106 Warsaw, Poland.; Institute of Biochemistry and Biophysics, Polish Academy of Sciences, 02-106 Warsaw, Poland., Czarnecka AM; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland., Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.
Publikováno v:
Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Jan 05; Vol. 31 (1), pp. 307-323. Date of Electronic Publication: 2024 Jan 05.
Autor:
Sobiborowicz A; Laboratory of Experimental Medicine, Centre of New Technologies, University of Warsaw, Poland.; Department of Soft Tissue/Bone Sarcoma and Melanoma, 49585Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Spałek MJ; Department of Soft Tissue/Bone Sarcoma and Melanoma, 49585Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Czarnecka AM; Department of Soft Tissue/Bone Sarcoma and Melanoma, 49585Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Department of Experimental Pharmacology, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland., Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, 49585Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Publikováno v:
Cancer control : journal of the Moffitt Cancer Center [Cancer Control] 2021 Jan-Dec; Vol. 28, pp. 1073274820983028.
Autor:
Sobczuk P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland; Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland. Electronic address: pawel.sobczuk@pib-nio.pl., Teterycz P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Czarnecka AM; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland; Department of Experimental Pharmacology, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland., Świtaj T; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Koseła-Paterczyk H; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Kozak K; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Falkowski S; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Goryń T; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Zdzienicki M; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Morysiński T; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Publikováno v:
Surgical oncology [Surg Oncol] 2020 Dec; Vol. 35, pp. 276-284. Date of Electronic Publication: 2020 Sep 12.
Autor:
D'Ambrosio L; Department of Oncology, University of Turin, Turin, Italy.; Sarcoma Unit, Division of Medical Oncology, Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy., Touati N; European Organization for Research and Treatment of Cancer, Brussels, Belgium., Blay JY; Leon Berard Center and Claude Bernard Lyon I University, EURACAN, LYRICAN, Lyon, France., Grignani G; Sarcoma Unit, Division of Medical Oncology, Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy., Flippot R; Department of Medicine, Gustave Roussy, Villejuif Cedex, France., Czarnecka AM; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute-Oncology Center, Gliwice, Poland.; Department of Experimental Pharmacology, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland., Piperno-Neumann S; Medical Oncology Department, Curie Institute, Paris, France., Martin-Broto J; Virgen del Rocio University Hospital, Institute of Biomedicine Research/CSIC/University of Seville, Seville, Spain., Sanfilippo R; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Katz D; Oncology Department, Sharett Institute of Oncology, Hadassah-Hebrew University, Jerusalem, Israel., Duffaud F; Medical Oncology - University Hospital Timone, Aix-Marseille University, Marseille, France., Vincenzi B; Department of Medical Oncology, Campus Bio-Medico University of Rome, Rome, Italy., Stark DP; St James's Institute of Oncology, Leeds Institute of Cancer and Pathology, University of Leeds and Leeds Teaching Hospitals National Health Service Trust, Leeds, United Kingdom., Mazzeo F; Medical Oncology, Clinique Universitaire Saint-Luc, Woluwe-Saint-Lambert, Belgium., Tuchscherer A; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany., Chevreau C; Claudius Regaud Institute, University Cancer Institute of Toulouse, Toulouse, France., Sherriff J; Cancer Centre, Queen Elizabeth Hospital, Birmingham, United Kingdom., Estival A; Catalan Institute of Oncology, Barcelona, Spain., Litière S; European Organization for Research and Treatment of Cancer, Brussels, Belgium., Sents W; European Organization for Research and Treatment of Cancer, Brussels, Belgium., Ray-Coquard I; Leon Berard Center and Claude Bernard Lyon I University, EURACAN, LYRICAN, Lyon, France., Tolomeo F; Sarcoma Unit, Division of Medical Oncology, Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy., Le Cesne A; Department of Medicine, Gustave Roussy, Villejuif Cedex, France., Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute-Oncology Center, Gliwice, Poland.; Department of Experimental Pharmacology, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland., Stacchiotti S; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Kasper B; Sarcoma Unit, Interdisciplinary Tumor Center, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands., Gronchi A; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Publikováno v:
Cancer [Cancer] 2020 Jun 01; Vol. 126 (11), pp. 2637-2647. Date of Electronic Publication: 2020 Mar 04.
Autor:
Frezza AM; Department of Medical Oncology, IRCCS Fondazione Istituto Nazionale Tumori, Milan, Italy., Assi T; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France., Lo Vullo S; Unit of Clinical Epidemiology and Trial Organization, IRCCS Fondazione Istituto Nazionale Tumori, Milan, Italy., Ben-Ami E; Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Dufresne A; Department of Medical Oncology, Centre Léon Bérard & Université Claude Bernard Lyon I, Lyon, France., Yonemori K; Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan., Noguchi E; Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan., Siontis B; Department of Medicine, University of Michigan, Ann Arbor, Michigan., Ferraro R; Department of Medicine, Sarcoma Medical Oncology, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York., Teterycz P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland., Duffaud F; Department of Medical Oncology, La Timone University Hospital, Aix-Marseille Université, Marseille, France., Ravi V; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Vincenzi B; Department of Medical Oncology, Università Campus Bio-Medico di Roma, Rome, Italy., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands., Pantaleo MA; Department of Specialized, Experimental and Diagnostic Medicine, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy., Baldi GG; Department of Medical Oncology, Nuovo Ospedale 'S. Stefano,', Prato, Italy., Desar I; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Fedenko A; Department of Medical Oncology, N. N. Blokhin Russian Cancer Research, Moscow, Russian Federation., Maki RG; Medical Oncology, Northwell Cancer Institute and Cold Spring Harbor Laboratory, Long Island, New York., Jones RL; Sarcoma Unit, Royal Marsden NHS Foundation Trust/Institute of Cancer Research, London, United Kingdom., Benjamin RS; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Blay JY; Department of Medical Oncology, Centre Léon Bérard & Université Claude Bernard Lyon I, Lyon, France., Kawai A; Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan., Gounder M; Department of Medicine, Sarcoma Medical Oncology, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York., Gronchi A; Sarcoma Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Le Cesne A; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France., Mir O; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France., Czarnecka AM; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland., Schuetze S; Department of Medicine, University of Michigan, Ann Arbor, Michigan., Wagner AJ; Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Adam J; Department of Pathology, Gustave Roussy Cancer Campus, Villejuif, France., Barisella M; Department of Diagnostic Pathology and Laboratory Medicine, IRCCS Fondazione Istituto Nazionale dei Tumori, Milan, Italy., Sbaraglia M; Department of Pathology, Treviso Regional Hospital, Italy., Hornick JL; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Meurgey A; Department of Biopathology, Centre Léon Bérard, Lyon, France., Mariani L; Unit of Clinical Epidemiology and Trial Organization, IRCCS Fondazione Istituto Nazionale Tumori, Milan, Italy., Casali PG; Department of Medical Oncology, IRCCS Fondazione Istituto Nazionale Tumori, Milan, Italy.; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy., Thornton K; Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Stacchiotti S; Department of Medical Oncology, IRCCS Fondazione Istituto Nazionale Tumori, Milan, Italy.
Publikováno v:
Cancer [Cancer] 2020 Jan 01; Vol. 126 (1), pp. 98-104. Date of Electronic Publication: 2019 Sep 19.
Publikováno v:
Cancer Management and Research, Vol Volume 15, Pp 615-623 (2023)
Anna M Czarnecka,1 Jacek Skoczylas,1 Ewa Bartnik,2,3 Tomasz Świtaj,1 Piotr Rutkowski1 1Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland; 2Institute of Genetics
Externí odkaz:
https://doaj.org/article/2e9ccae2c54b45f6824cd63f631c1c25